The E-selectin ligand activity of the bone metastatic ZR-75-1 breast carcinoma cell line was tested by perfusing the breast cancer cells over IL-1β activated HUVECs under physiological flow conditions in the parallel plate flow chamber adhesion assay. Here, SELE is linked to breast carcinoma.